SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-24-134515
Filing Date
2024-05-09
Accepted
2024-05-08 20:44:32
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-1/A d827405ds1a.htm S-1/A 419100
2 EX-1.1 d827405dex11.htm EX-1.1 39537
3 EX-4.11 d827405dex411.htm EX-4.11 95409
4 EX-4.14 d827405dex414.htm EX-4.14 93126
5 EX-10.19 d827405dex1019.htm EX-10.19 191213
6 EX-23.1 d827405dex231.htm EX-23.1 2001
7 EX-FILING FEES d827405dexfilingfees.htm EX-FILING FEES 33833
8 GRAPHIC g827405g85a01.jpg GRAPHIC 47299
  Complete submission text file 0001193125-24-134515.txt   940528
Mailing Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339
Business Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339 678-392-3419
Inhibikase Therapeutics, Inc. (Filer) CIK: 0001750149 (see all company filings)

IRS No.: 263407249 | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-278844 | Film No.: 24928150
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)